Cinqaero 25 mg/2,5 mL, Konzentrat zur Herstellung einer Infusionslösung
7680663400022
CH-66340
Konzentrat
Associated product:
Cinqaero conc perf 25 mg/2.5 ml, , Cinqaero conc perf 25 mg/2.5 ml flac 2.5 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
reslizumabum
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.35 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 155.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2018
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66340
- Drug name
- Cinqaero, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- R03DX08
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 09/11/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 03.04.5.
- Domain
- Human medicine
Package details
- Description (FR)
- CINQAERO conc perf 25 mg/2.5ml flac 2.5 ml
- Description (DE)
- CINQAERO Inf Konz 25 mg/2.5ml Durchstf 2.5 ml
- Market launch
- 12/07/2018
- Market withdrawal
- 13/03/2026
- Narcotic (BTM)
- No
Other package sizes (2)
CINQAERO conc perf 10 mg/1ml flac 10 ml
None None
GTIN: 7680663400015
CINQAERO conc perf 100 mg/10ml flac 10 ml
1 DUR
GTIN: 7680663400039